Best Dermatologists for Skin Biopsy in India

A skin lesion requiring biopsy is any growth, sore, pigmented area, or structural change on the skin that displays features — such as irregular borders, asymmetry, rapid change, bleeding, or unusual colour — that a clinician considers insufficient to classify with confidence on examination alone, making tissue sampling necessary for a definitive diagnosis.

Concerning features that may prompt a biopsy referral include a mole or pigmented patch that is asymmetrical, has an irregular or poorly defined border, contains multiple colours, has grown beyond six millimetres, or has changed noticeably over weeks to months; a non-healing ulcer or sore; a firm, pearly, or translucent nodule; or a scaly, thickened plaque that bleeds easily. Some lesions that turn out to be significant cause no pain or discomfort at all, while others may itch, crust, or ooze. The presence or absence of these symptoms alone is not sufficient to confirm or exclude any particular diagnosis — a qualified clinician must evaluate each case individually.

Diagnosis begins with a thorough clinical history — including sun exposure habits, personal and family history of skin cancer, immunosuppression status, and how the lesion has changed over time — followed by a dermoscopic examination, which uses magnification and polarised light to assess subsurface structures. If dermoscopy does not provide sufficient clarity, a biopsy is performed; depending on the lesion's size, location, and suspected type, this may be an incisional, excisional, punch, or shave biopsy, with the tissue sent for histopathological analysis. For lesions confirmed as malignant, further staging investigations — such as sentinel lymph node assessment or imaging — may be required to determine whether spread has occurred.

The appropriate management depends entirely on the biopsy result, lesion type, depth or stage, location, and the patient's overall health, and must be determined through individual clinical assessment. Confirmed malignant lesions such as melanoma or squamous cell carcinoma typically require surgical removal with defined clear margins, most often through wide local excision, and may additionally involve sentinel lymph node biopsy, topical or systemic therapies, radiotherapy, or immunotherapy depending on stage. Benign lesions confirmed on histology may require no further treatment, or may be managed with monitoring, cryotherapy, topical agents, or minor surgical removal based on the patient's symptoms and preferences.

For lesions confirmed as benign, non-surgical options such as active surveillance, cryotherapy (freezing), topical prescription creams (for example, those used for superficial actinic keratoses or certain low-risk basal cell carcinomas), or photodynamic therapy may be appropriate depending on the specific diagnosis and clinical context. However, for lesions confirmed as malignant melanoma or high-risk skin cancers, surgical excision is generally the primary treatment; non-surgical approaches alone are not considered sufficient and any decision to use adjunctive therapies must be guided by a specialist.

Skin Biopsy may be considered only when it is appropriate for the confirmed diagnosis and the expected benefit outweighs the individual risks. The decision may depend on symptom severity, investigation results, previous treatment, overall health and the patient's goals. A specialist should discuss alternatives and recovery before any procedure is planned.

Skin lesions requiring biopsy are primarily evaluated and managed by a dermatologist, who performs the clinical assessment and biopsy; if a lesion is confirmed malignant, care is typically coordinated by a dermatologist alongside a plastic surgeon or surgical oncologist for excision, and may involve a multidisciplinary team including a medical oncologist or radiation oncologist depending on stage and type.

When selecting a provider, it is worth asking about the clinician's specific experience with dermoscopy and the type of lesion suspected, whether histopathology is processed by a specialist dermatopathology laboratory, and whether the facility offers access to a multidisciplinary skin cancer team and clear pathways for follow-up or further treatment if results require it.

Share a concise medical summary, symptom timeline, previous diagnoses, investigation and imaging reports, procedure or biopsy reports where relevant, current medicines, allergies and related treatment records. Provide clear copies with translations when needed. The reviewing doctor may request additional information before giving an opinion.

Our care coordination team can review the initial information, help identify suitable doctors and hospitals, request a medical opinion where available, explain next steps and indicative cost information, and support practical planning before travel. A remote opinion does not replace an in-person examination or emergency care.